A directory of where to buy chemicals in the USA, including: distributors, industrial manufacturers, bulk supplies and wholesalers of raw ingredients & finished goods.
Search for products or services, then visit the suppliers website for prices or more information.
| Product | Description | |
|---|---|---|
| 4arm-PEG20K-Succinimidyl Glutarate | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: 4arm-PEG-Succinimidyl Glutarate. Molecular formula: average Mn 20000. |  |
| 4arm-PEG20K-Succinimidyl Glutarate | average Mn 20,000. Group: Poly(ethylene glycol) and poly(ethylene oxide). |  |
| 4arm-PEG20K-Succinimidyl Succinate | average Mn 20,000. Group: Poly(ethylene glycol) and poly(ethylene oxide). | |
| 4arm-PEG20K-Succinimidyl Succinate | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: 4arm-PEG-Succinimidyl Succinate. Molecular formula: average Mn 20000. | |
| 4arm-PEG20K-Vinylsulfone | average Mn 20,000. Group: Poly(ethylene glycol) and poly(ethylene oxide). | |
| 4arm-PEG20K-Vinylsulfone | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: 4arm-PEG-VS, 4arm-PEG-Vinylsulfone. Molecular formula: average Mn 20000. | |
| 4arm-PEG2500-PCL2500 | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: 4arm-PEG-PCL. Molecular formula: PCL average Mn 2,500 PEG average Mn 2,500. | |
| 4arm-PEG2500-PCL2500 | PEG average Mn 2,500, PCL average Mn 2,500. Group: Poly(ethylene glycol) and poly(ethylene oxide). | |
| 4arm-PEG2500-PLA3500 | PEG average Mn 2,500, PCL average Mn 3,500. Group: Poly(ethylene glycol) and poly(ethylene oxide). | |
| 4arm-PEG2500-PLA3500 | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: 4arm-PEG-PLA. Molecular formula: PCL average Mn 3,500 PEG average Mn 2,500. | |
| 4arm-PEG2K-NH2 | average Mn 2,000. Group: Poly(ethylene glycol) and poly(ethylene oxide). | |
| 4arm-PEG2K-NH2 | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: 4arm-PEG-NH2, 4arm-PEG-amine. Molecular formula: average Mn 2000. | |
| 4arm-PEG3K 3arm-OH, 1arm-COOH | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Molecular formula: average Mn 3000. | |
| 4arm-PEG3K 3arm-OH, 1arm-COOH | average Mn 3000. Group: Poly(ethylene glycol) and poly(ethylene oxide). | |
| 4arm-PEG40K-COOH | average Mn 40,000. Group: Poly(ethylene glycol) and poly(ethylene oxide). | |
| 4arm-PEG40K-COOH | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: 4arm-PEG-COOH, 4arm-PEG-Carboxyl. Molecular formula: average Mn 40000. | |
| 4arm-PEG40K-Maleimide | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: 4arm-PEG-MAL, 4arm-PEG-Maleimide. Molecular formula: average Mn 40000. | |
| 4arm-PEG40K-Maleimide | average Mn 40,000. Group: Poly(ethylene glycol) and poly(ethylene oxide). | |
| 4arm-PEG40K-NH2 | HCl Salt, average Mn 40,000. Group: Poly(ethylene glycol) and poly(ethylene oxide). | |
| 4arm-PEG40K-NH2 | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: 4arm-PEG-NH2, 4arm-PEG-amine. Molecular formula: average Mn 40000. | |
| 4arm-PEG40K-Succinimidyl Carboxymethyl Ester | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: 4arm-PEG-Succinimidyl Carboxymethyl Ester. Molecular formula: average Mn 40000. | |
| 4arm-PEG40K-Succinimidyl Carboxymethyl Ester | average Mn 40,000. Group: Poly(ethylene glycol) and poly(ethylene oxide). | |
| 4arm-PEG40K-Succinimidyl Glutarate | average Mn 40,000. Group: Poly(ethylene glycol) and poly(ethylene oxide). | |
| 4arm-PEG40K-Succinimidyl Glutarate | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: 4arm-PEG-Succinimidyl Glutarate. Molecular formula: average Mn 40000. | |
| 4arm-PEG40K-Succinimidyl Succinate | average Mn 40,000. Group: Poly(ethylene glycol) and poly(ethylene oxide). | |
| 4arm-PEG40K-Succinimidyl Succinate | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: 4arm-PEG-Succinimidyl Succinate. Molecular formula: average Mn 40000. | |
| 4arm-PEG5K 1arm-OH, 3arm-COOH | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Molecular formula: average Mn 5000. | |
| 4arm-PEG5K 1arm-OH, 3arm-COOH | average Mn 5000. Group: Poly(ethylene glycol) and poly(ethylene oxide). | |
| 4arm-PEG5K 3arm-OH, 1arm-COOH | average Mn 5000. Group: Poly(ethylene glycol) and poly(ethylene oxide). | |
| 4arm-PEG5K 3arm-OH, 1arm-COOH | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Molecular formula: average Mn 5000. | |
| 4arm-PEG5K-COOH | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: 4arm-PEG-COOH, 4arm-PEG-Carboxyl. Molecular formula: average Mn 5000. | |
| 4arm-PEG5K-COOH | average Mn 5,000. Group: Poly(ethylene glycol) and poly(ethylene oxide). | |
| 4arm-PEG5K-NH2 | HCl Salt, average Mn 5,000. Group: Poly(ethylene glycol) and poly(ethylene oxide). | |
| 4arm-PEG5K-NH2 | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: 4arm-PEG-NH2, 4arm-PEG-amine. Molecular formula: average Mn 5000. | |
| 4arm-PEG5K-SH | average Mn 5,000. Group: Poly(ethylene glycol) and poly(ethylene oxide). | |
| 4arm-PEG5K-SH | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: 4arm-PEG-SH. Molecular formula: average Mn 5000. | |
| 4arm-PEG5K-Succinimidyl Carboxymethyl Ester | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: 4arm-PEG-Succinimidyl Carboxymethyl Ester. Molecular formula: average Mn 5000. | |
| 4arm-PEG5K-Succinimidyl Carboxymethyl Ester | average Mn 5,000. Group: Poly(ethylene glycol) and poly(ethylene oxide). | |
| 4arm-PEG GPC Standards | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). | |
| 4-arm Poly(ethylene glycol) norbornene terminated | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: PEG-norbornene, PEG-nb. CAS No. 1191287-92-9. Pack Sizes: Packaging 1 g in glass bottle. Molecular formula: average Mn 10000. | |
| 4arm-Poly(lactide-co-glycolide) | 4arm-Poly(lactide-co-glycolide). Synonyms: 4 arm PLGA. Product ID: MSMN-066. Category: Raw Materials. |  |
| 4-Aza-3-chromanone | 4-Aza-3-chromanone. Group: Biochemicals. Alternative Names: 2H-1,4-Benzoxazine-3(4H)-one; 2H-Benzo[b][1,4]oxazin-3(4H)-one. Grades: Highly Purified. CAS No. 5466-88-6. Pack Sizes: 25g, 50g, 100g, 250g. Molecular Formula: C8H7NO2. US Biological Life Sciences. |  Worldwide |
| 4-Aza-3-chromanone 98+% (HPLC) | 4-Aza-3-chromanone 98+% (HPLC). Group: Biochemicals. Grades: Reagent Grade. Pack Sizes: 5g, 25g, 100g, 250g. US Biological Life Sciences. | Worldwide |
| 4-azabenzimidazole | 4-azabenzimidazole. Uses: Designed for use in research and industrial production. Product Category: Imidazoles. Appearance: Yellow to light brown powder. CAS No. 273-21-2. Molecular formula: C6H5N3. Mole weight: 119.12. Purity: 0.99. Density: 1.38 g/cm³. Product ID: ACM273212. Alfa Chemistry ISO 9001:2015 Certified. |  |
| 4-Aza-dl-leucine dihydrochloride | 4-Aza-dl-leucine dihydrochloride. Uses: Designed for use in research and industrial production. Appearance: White to off white powder. CAS No. 102029-69-6. Molecular formula: C5H12N2O2·2HCl. Mole weight: 205.08. Purity: 0.96. IUPACName: 2-amino-3-(dimethylamino)propanoicacid;dihydrochloride. Canonical SMILES: CN(C)CC(C(=O)O)N.Cl.Cl. Product ID: ACM102029696. Alfa Chemistry ISO 9001:2015 Certified. Categories: 34064-27-2. | |
| 4-Azaindole | 4-Azaindole. Group: Biochemicals. Grades: Highly Purified. CAS No. 272-49-1. Pack Sizes: 1g, 2g, 5g, 10g, 25g. Molecular Formula: C7H6N2. US Biological Life Sciences. | Worldwide |
| 4-Azaindole | 1g Pack Size. Group: Building Blocks, Indoles, Organics, Stains & Indicators. Formula: C7H6N2. CAS No. 272-49-1. Prepack ID 26737614-1g. Molecular Weight 118.14. See USA prepack pricing. |  |
| 4-Azaindole | 1H-Pyrrolo[3,2-b]pyridine is a biochemical reagent that can be used as a biological material or organic compound for life science related research. Uses: Scientific research. Group: Biochemical assay reagents. CAS No. 272-49-1. Pack Sizes: 5 g; 10 g. Product ID: HY-20362. |  |
| 4-Azaindole 98+% (HPLC) | 4-Azaindole 98+% (HPLC). Group: Biochemicals. Grades: Reagent Grade. Pack Sizes: 1g, 5g, 25g. US Biological Life Sciences. | Worldwide |
| 4-Azaphthalide | 4-Azaphthalide. CAS No: 5657-51-2 |  Sarchem Laboratories New Jersey NJ |
| 4'-Azetidinomethyl-2-thiomethylbenzophenone | 4'-Azetidinomethyl-2-thiomethylbenzophenone. Uses: Designed for use in research and industrial production. Additional or Alternative Names: 4'-AZETIDINOMETHYL-2-THIOMETHYLBENZOPHENONE. Product Category: Heterocyclic Organic Compound. CAS No. 898756-34-8. Molecular formula: C18H19NOS. Mole weight: 297.41. Purity: 0.96. IUPACName: [4-(azetidin-1-ylmethyl)phenyl]-(2-methylsulfanylphenyl)methanone. Canonical SMILES: CSC1=CC=CC=C1C(=O)C2=CC=C(C=C2)CN3CCC3. Density: 1.2g/cm³. Product ID: ACM898756348. Alfa Chemistry ISO 9001:2015 Certified. | |
| 4'-Azetidinomethyl-3,4-dichlorobenzophenone | 4'-Azetidinomethyl-3,4-dichlorobenzophenone. Uses: Designed for use in research and industrial production. Additional or Alternative Names: 4'-AZETIDINOMETHYL-3,4-DICHLOROBENZOPHENONE. Product Category: Heterocyclic Organic Compound. CAS No. 898757-00-1. Molecular formula: C17H15Cl2NO. Mole weight: 320.21. Purity: 0.96. IUPACName: [4-(azetidin-1-ylmethyl)phenyl]-(3,4-dichlorophenyl)methanone. Canonical SMILES: C1CN(C1)CC2=CC=C(C=C2)C(=O)C3=CC(=C(C=C3)Cl)Cl. Density: 1.321g/cm³. Product ID: ACM898757001. Alfa Chemistry ISO 9001:2015 Certified. | |
| 4'-Azetidinomethyl-3-trifluoromethylbenzophenone | 4'-Azetidinomethyl-3-trifluoromethylbenzophenone. Uses: Designed for use in research and industrial production. Additional or Alternative Names: 4'-AZETIDINOMETHYL-3-TRIFLUOROMETHYLBENZOPHENONE. Product Category: Heterocyclic Organic Compound. CAS No. 898756-84-8. Molecular formula: C18H16F3NO. Mole weight: 319.32. Purity: 0.96. IUPACName: [4-(azetidin-1-ylmethyl)phenyl]-[3-(trifluoromethyl)phenyl]methanone. Canonical SMILES: C1CN(C1)CC2=CC=C(C=C2)C(=O)C3=CC(=CC=C3)C(F)(F)F. Density: 1.267g/cm³. Product ID: ACM898756848. Alfa Chemistry ISO 9001:2015 Certified. | |
| 4'-Azetidinomethyl-4-bromo-3-fluorobenzophenone | 4'-Azetidinomethyl-4-bromo-3-fluorobenzophenone. Uses: Designed for use in research and industrial production. Additional or Alternative Names: 4'-AZETIDINOMETHYL-4-BROMO-3-FLUOROBENZOPHENONE. Product Category: Heterocyclic Organic Compound. CAS No. 898756-73-5. Molecular formula: C17H15BrFNO. Mole weight: 348.21. Purity: 0.96. IUPACName: [4-(azetidin-1-ylmethyl)phenyl]-(4-bromo-3-fluorophenyl)methanone. Canonical SMILES: C1CN(C1)CC2=CC=C(C=C2)C(=O)C3=CC(=C(C=C3)Br)F. Density: 1.457g/cm³. Product ID: ACM898756735. Alfa Chemistry ISO 9001:2015 Certified. | |
| 4'-Azetidinomethyl-4-chloro-3-fluorobenzophenone | 4'-Azetidinomethyl-4-chloro-3-fluorobenzophenone. Uses: Designed for use in research and industrial production. Additional or Alternative Names: 4'-AZETIDINOMETHYL-4-CHLORO-3-FLUOROBENZOPHENONE. Product Category: Heterocyclic Organic Compound. CAS No. 898756-75-7. Molecular formula: C17H15ClFNO. Mole weight: 303.76. Purity: 0.96. IUPACName: [4-(azetidin-1-ylmethyl)phenyl]-(4-chloro-3-fluorophenyl)methanone. Canonical SMILES: C1CN(C1)CC2=CC=C(C=C2)C(=O)C3=CC(=C(C=C3)Cl)F. Density: 1.294g/cm³. Product ID: ACM898756757. Alfa Chemistry ISO 9001:2015 Certified. | |
| 4-Azetidinomethyl-4'-thiomethylbenzophenone | 4-Azetidinomethyl-4'-thiomethylbenzophenone. Uses: Designed for use in research and industrial production. Additional or Alternative Names: 4-AZETIDINOMETHYL-4'-THIOMETHYLBENZOPHENONE. Product Category: Heterocyclic Organic Compound. CAS No. 898756-37-1. Molecular formula: C18H19NOS. Mole weight: 297.41. Purity: 0.96. IUPACName: [4-(azetidin-1-ylmethyl)phenyl]-(4-methylsulfanylphenyl)methanone. Canonical SMILES: CSC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)CN3CCC3. Density: 1.2g/cm³. Product ID: ACM898756371. Alfa Chemistry ISO 9001:2015 Certified. | |
| 4-(Azetidinomethyl)benzophenone | 4-(Azetidinomethyl)benzophenone. Uses: Designed for use in research and industrial production. Additional or Alternative Names: 4-(AZETIDINOMETHYL) BENZOPHENONE. Product Category: Heterocyclic Organic Compound. CAS No. 898777-22-5. Molecular formula: C17H17NO. Mole weight: 251.32. Purity: 0.96. IUPACName: [4-(azetidin-1-ylmethyl)phenyl]-phenylmethanone. Canonical SMILES: C1CN(C1)CC2=CC=C(C=C2)C(=O)C3=CC=CC=C3. Density: 1.15g/cm³. Product ID: ACM898777225. Alfa Chemistry ISO 9001:2015 Certified. | |
| 4-(Azetidinomethyl)phenyl cyclohexyl ketone | 4-(Azetidinomethyl)phenyl cyclohexyl ketone. Uses: Designed for use in research and industrial production. Additional or Alternative Names: 898757-16-9, 4-(AZETIDIN-1-YLMETHYL)PHENYL CYCLOHEXYL KETONE, CTK5G4110, AKOS016020149, AG-H-63959, 4-(azetidinomethyl)phenyl cyclohexyl ketone. Product Category: Heterocyclic Organic Compound. CAS No. 898757-16-9. Molecular formula: C17H23NO. Mole weight: 257.37896. Purity: 0.96. IUPACName: [4-(azetidin-1-ylmethyl)phenyl]-cyclohexylmethanone. Canonical SMILES: C1CCC(CC1)C(=O)C2=CC=C(C=C2)CN3CCC3. Density: 1.098g/cm³. Product ID: ACM898757169. Alfa Chemistry ISO 9001:2015 Certified. | |
| 4-(Azetidinomethyl)phenyl cyclopropyl ketone | 4-(Azetidinomethyl)phenyl cyclopropyl ketone. Uses: Designed for use in research and industrial production. Additional or Alternative Names: 4-(AZETIDINOMETHYL)PHENYL CYCLOPROPYL KETONE. Product Category: Heterocyclic Organic Compound. CAS No. 898757-10-3. Molecular formula: C14H17NO. Mole weight: 215.29. Purity: 0.96. IUPACName: [4-(azetidin-1-ylmethyl)phenyl]-cyclopropylmethanone. Canonical SMILES: C1CN(C1)CC2=CC=C(C=C2)C(=O)C3CC3. Density: 1.188g/cm³. Product ID: ACM898757103. Alfa Chemistry ISO 9001:2015 Certified. | |
| 4-Azido-1-methanesulfonate-1-butanol | Used in the preparation of (R)-Sulforaphane. Group: Biochemicals. Alternative Names: 4-Azidomethanesulfonate-1-butanol. Grades: Highly Purified. CAS No. 320573-75-9. Pack Sizes: 50mg. US Biological Life Sciences. | Worldwide |
| 4-Azido-2,2,6,6-tetramethyl-1-piperidinyloxy | An intermediate in the preparation of 4-Amino-2,2,6,6-tetra-methyl Piperidine-1-oxyl. Group: Biochemicals. Alternative Names: 2,2,6,6-Tetramethyl-4-azide-piperidin-1-oxyl; 4-Azido-2,2,6,6-tetramethylpiperidin-1-yloxy; NSC 300606. Grades: Highly Purified. CAS No. 63697-61-0. Pack Sizes: 250mg. US Biological Life Sciences. | Worldwide |
| 4-Azido-2,2,6,6-tetramethylpiperidine N-oxide | An intermediate in the preparation of 4-Amino-2,2,6,6-tetra-methyl Piperidine-1-oxyl. Uses: An intermediate in the preparation of 4-amino-2,2,6,6-tetra-methyl piperidine-1-oxyl. Synonyms: 4-Azido-TEMPON3-TEMPO; 4-Azido-1-hydroxy-2,2,6,6-tetramethylpiperidine; 4-Azido-2,2,6,6-tetramethyl-1-piperidinyloxy; 2,2,6,6-Tetramethyl-4-azide-piperidin-1-oxyl; 4-Azido-2,2,6,6-tetramethylpiperidin-1-yloxy. Grades: ≥ 98% (HPLC). CAS No. 63697-61-0. Molecular formula: C9H17N4O. Mole weight: 197.27. |  |
| 4-Azido-2,3,5,6-tetrafluorobenzamide | 4-Azido-2,3,5,6-tetrafluorobenzamide. Group: Biochemicals. Grades: Highly Purified. Pack Sizes: 25mg. US Biological Life Sciences. | Worldwide |
| 4-Azido-2, 3, 5, 6-tetra fluoro benzamidocysteine Methanethiosulfonate | A trifunctional, photo and thiol reactive reagent. Group: Biochemicals. Grades: Highly Purified. Pack Sizes: 10mg. US Biological Life Sciences. | Worldwide |
| 4-Azido-2,3,5,6-tetrafluorobenzamido-L-cysteine methanethiosulfonate | 4-Azido-2,3,5,6-tetrafluorobenzamido-L-cysteine methanethiosulfonate. Group: Biochemicals. Alternative Names: N-(4-Azido-2,3,5,6-tetrafluorobenzoyl)-L-cysteine methanesulfonate. Grades: Highly Purified. CAS No. 352000-06-7. Pack Sizes: 5mg, 10mg, 25mg, 50mg, 100mg. Molecular Formula: C11H8F4N4O5S2. US Biological Life Sciences. | Worldwide |
| 4-Azido-2,3,5,6-tetrafluorobenzoic Acid | A fluorinated aryl azide that has been used as a photo-cross linker to study the estrogen receptor.l max = 258nm; e= 17 x 10-3. Group: Biochemicals. Grades: Highly Purified. Pack Sizes: 100mg. US Biological Life Sciences. | Worldwide |
| 4-Azido-2,3,5,6-tetrafluoro-N-(2-methacrylamidoethyl)benzamide | 4-Azido-2,3,5,6-tetrafluoro-N-(2-methacrylamidoethyl)benzamide. Uses: Designed for use in research and industrial production. Additional or Alternative Names: 4-Azido-2,3,5,6-tetrafluoro-N-[2-[(2-methyl-1-oxo-2-propen-1-yl)amino]ethyl]benzamide; 4-Azido-2,3,5,6-tetrafluoro-N-[2-(methacryloylamino)ethyl]benzamide. Product Category: Methacrylamide Monomers. Appearance: White to Light Yellow Powder to Crystal. CAS No. 2361935-10-4. Molecular formula: C13H11F4N5O2. Mole weight: 345.26 g/mol. Purity: 98.0%(T)(HPLC). Product ID: ACM-MO-2361935104. Alfa Chemistry ISO 9001:2015 Certified. | |
| 4-Azido-2,3-di-O-benzoyl-4-deoxy-6-O-trityl-a-D-glucopyranoside | 4-Azido-2,3-di-O-benzoyl-4-deoxy-6-O-trityl-α-D-glucopyranoside is a versatile compound widely used in biomedical field. It serves as a powerful tool for studying biological processes due to its ability to selectively label glycoproteins and glycopeptides. Molecular formula: C39H33N3O7. Mole weight: 655.7. | |
| 4'-Azido-2'-deoxy-2'-fluoro-N4-(n-palmitoyl)arabinocytidine | 4'-Azido-2'-deoxy-2'-fluoro-N4-(n-palmitoyl)arabinocytidine is an intriguing biomedical product, holds substantial potential in combatting viral infections. Its mechanism of action lies in the inhibition of viral replication, targeting RNA viruses with remarkable precision. Notably, this compound exhibiting promising efficacy against a multitude of RNA virus-induced diseases. Grades: ≥95%. Molecular formula: C25H41FN6O5. Mole weight: 524.63. | |
| 4'-Azido-3'-O-benzoyl-5'-O-(m-chlorobenzoyl)-2'-deoxy-2'-fluoro-beta-D-arabinouridine | 4'-Azido-3'-O-benzoyl-5'-O-(m-chlorobenzoyl)-2'-deoxy-2'-fluoro-beta-D-arabinouridine is an influential antiviral compound, specifically designed to impede the replication of targeted viruses like HIV and herpes simplex virus (HSV). Its inherent capability to disrupt viral DNA research and development manifesting in restraining viral propagation. Synonyms: 1-[4-Azido-3-O-benzoyl-5-O-(3-chlorobenzoyl)-(2-deoxy-2-fluoro-b-D-arabinofuranosyl)uracil; 4'-Azido-3'-O-benzoyl-5'-O-(m-chlorobenzyl)-2'-deoxy-2'-fluoro-β-Darabinouridine; [(2R,3R,4S,5R)-2-Azido-3-(benzoyloxy)-5-(2,4-dioxo-3,4-dihydro-1(2H)-pyrimidinyl)-4-fluorotetrahydro-2-furanyl]methyl 3-chlorobenzoate. Grades: ≥95%. CAS No. 1333126-30-9. Molecular formula: C23H17ClFN5O7. Mole weight: 529.86. | |
Our database is helping our users find suppliers everyday.
